Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
SGLT2
Pharma
In push to boost Kerendia, Bayer adds 3 heart failure trials
Bayer plans three new trials to assess Kerendia in heart failure. The drug was first approved 2 years ago in CKD associated with diabetes.
Kevin Dunleavy
Sep 1, 2023 11:03am
AZ's Dobber talks SGTL2, GLP-1 clash in heart failure
Aug 29, 2023 1:30pm
TheracosBio brings on Connelly to replace Collinson as CEO
Aug 1, 2023 8:41am
TheracosBio, Cuban's Cost Plus team up to launch new SGLT2 drug
Jul 13, 2023 6:30am
Lexicon finally scores FDA nod for heart failure drug Inpefa
May 30, 2023 9:55am
AZ's Farxiga scores expanded heart failure nod
May 9, 2023 10:05am
